证券代码：688278 证券简称：特宝生物 公告编号：2025-030 厦门特宝生物工程股份有限公司 第九届监事会第八次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 部分限制性股票的议案》 经认真审议，监事会认为： 规定的禁止实施股权激励计划的情形，公司具备实施股权激励计划的主体资格。 人民共和国证券法》等法律、法规和规范性文件规定的任职资格，符合《上市 公司股权激励管理办法》及《上海证券交易所科创板股票上市规则》规定的激 励对象条件，符合公司《2024 年限制性股票激励计划（草案）》及其摘要规定 的激励对象范围，其作为公司 2024 年限制性股票激励计划预留授予激励对象的 主体资格合法、有效。 以及公司《2024 年限制性股票激励计划（草案）》及其摘要中有关授予日的相 关规定。 厦门特宝生物工程股份有限公司（以下简称"公司"）第九届监事会第八 次会议于 2025 年 9 月 4 日以现场结合通讯表决的方式召开。经全体监事同意， 一致豁免本次会议通知的期限要求，并已在会议上就豁免通知 ...

Meeting Overview - The company will hold its third extraordinary general meeting of shareholders in 2025 on September 22, 2025, at 14:30 [1] - The meeting will be conducted both in-person and via online voting [2] Voting Details - Online voting will occur on September 22, 2025, with specific time slots for participation [2] - Shareholders can vote either in person or through online platforms, but cannot vote twice [2][3] Shareholder Rights - All ordinary shareholders registered by the close of trading on September 15, 2025, are entitled to attend the meeting and vote [3] - Shareholders can appoint proxies to attend and vote on their behalf [3] Agenda Items - The meeting will review several proposals, including the authorization for the board to manage the 2025 employee stock ownership plan [4][5] - Certain related shareholders must abstain from voting on specific proposals [5] Proposal Voting Process - Proposals will be identified by specific codes, and shareholders can vote on individual proposals or a total proposal [5] - The voting results for small investors will be counted separately and disclosed publicly [5] Registration Process - Individual shareholders must present valid identification for registration, while corporate shareholders must provide proof of their legal representative [6] - Remote shareholders can register via mail, fax, or email, with a deadline of September 17, 2025 [6] Online Voting Instructions - Detailed procedures for online voting are provided, ensuring that the first valid vote is counted in case of duplicate submissions [7]

Group 1 - The company held a shareholders' meeting on September 5, 2025, at its headquarters in Hangzhou, Zhejiang Province [1] - The meeting was presided over by the chairman, Yang Shuiyu, and utilized both in-person and online voting methods, complying with legal and regulatory requirements [1][3] - All resolutions presented at the meeting were approved with significant majority votes, indicating strong shareholder support [2][3] Group 2 - The voting results showed that the majority of A-shareholders voted in favor of the resolutions, with percentages ranging from 99.4932% to 99.7045% for various proposals [2][3] - The company successfully elected its seventh board of directors, including both non-independent and independent directors, reflecting a stable governance structure [3] - Legal representatives confirmed that the meeting's procedures and voting results were valid and in accordance with applicable laws and regulations [3]

证券代码：301556 证券简称：托普云农 公告编号：2025-035 浙江托普云农科技股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 监事会认为本次子公司股权变更暨部分募投项目实施主体股权结构变化事 项，符合公司实际经营管理需要，募投项目实施主体股权权益实质上仍由公司 暨部分募投项目实施主体股权结构变化事项。 具体内容详见公司披露于巨潮资讯网（www.cninfo.com.cn）的《关于子公 司股权变更暨募投项目实施主体股权结构变化的公告》（2025-036）。 表决结果：3 票同意、0 票反对、0 票弃权。 三、备查文件 公司第四届监事会第八次会议决议。 一、监事会会议召开情况 浙江托普云农科技股份有限公司（以下简称"公司"）第四届监事会第八次 会议于 2025 年 9 月 5 日在公司会议室以现场及通讯结合的方式召开，会议通知 已于 2025 年 9 月 2 日以书面文件、电子邮件、钉钉、专人送达等方式送达全体 监事。本次会议应出席监事 3 名，实际出席监事 3 名。会议由监事会主席梁燕儿 女士主持。本次会议的召开符合《公司法》等有关法律法 ...

Meeting Details - The meeting was held on September 5, 2025, at 14:30, with online voting available from 9:15 to 15:00 on the same day [1] - The notice for the meeting was published on the official website [1] Attendance - A total of 114 participants attended the meeting, representing 120,640,400 shares, which is approximately 57.0% of the total voting shares [2] - 8 attendees were present at the meeting, representing 71,759,278 shares, about 33.9% of the total voting shares [2] - 106 participants voted online, representing 48,881,122 shares, approximately 23.1% of the total voting shares [2] Voting Results - The proposal received 120,614,180 votes in favor, accounting for 99.9951% of the valid votes cast [3][4] - Among minority shareholders, 18,548,361 votes were in favor, representing 99.8588% of their valid votes [3][4] - The proposal was classified as a special resolution and was approved with more than two-thirds of the voting rights [3] Legal Verification - The meeting was witnessed by Hubei Best Law Firm, with lawyers confirming the legality of the meeting's procedures and voting results [5]

Core Viewpoint - The legal opinion confirms that the procedures for convening and holding the 2025 First Extraordinary General Meeting of Guizhou Yibai Pharmaceutical Co., Ltd. comply with relevant laws and regulations, ensuring the legitimacy of the meeting and its resolutions [1][10]. Group 1: Meeting Procedures - The company announced the meeting on August 21, 2025, and published relevant materials on August 28, 2025, in compliance with legal requirements [2][3]. - The meeting was scheduled for September 5, 2025, and was conducted using a combination of on-site and online voting methods [3][4]. - The notice included details such as meeting type, time, location, and voting procedures, meeting the requirements of the Company Law and other regulations [4][9]. Group 2: Attendance and Qualifications - Shareholders registered by the close of trading on August 29, 2025, were eligible to attend the meeting, along with company directors, supervisors, and legal representatives [5][6]. - A total of 348 participants attended the meeting, representing 187,535,236 shares, which is approximately 1.06% of the total shares [5][6]. Group 3: Voting Procedures and Results - The meeting's voting was conducted through a named voting method, with all proposed resolutions receiving overwhelming support, with approval rates ranging from 98.11% to 98.65% [6][8]. - All resolutions, including the cancellation of the supervisory board and amendments to various internal regulations, were passed [7][8][9]. - The voting process and results were verified to be in accordance with the Company Law and other relevant regulations, confirming the legitimacy of the meeting's outcomes [9][10].

Group 1 - The law firm Beijing Zhonglun (Guangzhou) has been commissioned by Tianjin Yinlong Prestressed Materials Co., Ltd. to provide legal opinions for the company's 2025 first extraordinary general meeting of shareholders [1][2] - The legal opinions focus on the legality of the meeting's convening, procedures, attendance, and voting results, ensuring compliance with relevant laws and regulations [3][22] - The meeting was convened by the fifth board of directors, with a notice published on August 20, 2025, meeting the legal requirements for notification [4][5] Group 2 - A total of 15 shareholders attended the meeting in person, representing 21,388,259 shares, which is 2.4947% of the total voting shares [5][6] - The meeting was held on September 5, 2025, and was presided over by the financial director due to the chairman's absence [5][8] - The network voting involved 251 shareholders, representing 328,445,525 shares, which is 38.3097% of the total voting shares [6][8] Group 3 - The voting results for the proposals included significant support, with the proposal to change the company's registered capital receiving 99.9224% approval [9][11] - Other proposals, such as the cancellation of the supervisory board and amendments to the articles of association, also received over 99% approval [11][12] - All proposals were passed as special resolutions, meeting the requirement of two-thirds majority [9][12][22]

证券代码：603969 证券简称：银龙股份 公告编号：2025-050 天津银龙预应力材料股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一) 股东大会召开的时间：2025 年 9 月 5 日 (二) 股东大会召开的地点：天津市北辰区双源工业园区双江道 62 号 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： (四) 表决方式是否符合《公司法》及《公司章程》的规定，股东大会主持情况等。 本次会议由公司董事会召集，董事长谢志峰先生以视频方式参会，过半数董 事推选董事钟志超先生主持会议。本次会议采取现场投票及网络投票相结合的表 决方式，符合《中华人民共和国公司法》、中国证监会《上市公司股东会规则》 等相关法律、法规和《公司章程》的规定。 (一) 非累积投票议案 审议结果：通过 表决情况： | 股东类型 | 同意 | | | 反对 | | 弃权 | | | --- | --- | --- | --- | --- | -- ...

Meeting Overview - The shareholder meeting of Guizhou Yibai Pharmaceutical Co., Ltd. was held on September 5, 2025, at the company's administrative building meeting room [1] - The meeting was chaired by the chairman, Ms. Dou Qiling, and utilized a combination of on-site and online voting methods, complying with the Company Law and the company's articles of association [1] Voting Results - All proposed resolutions were passed with significant majority votes, with A-shareholders showing high approval rates ranging from 98.1052% to 98.6529% across various resolutions [2][3] - Specific voting results included: - 193,042,393 votes in favor (98.5460%), 2,681,326 against (1.3687%), and 166,900 abstentions (0.0853%) for one resolution [1] - 192,934,793 votes in favor (98.4910%), 2,760,626 against (1.4092%), and 195,200 abstentions (0.0998%) for another resolution [2] Legal Compliance - The meeting's procedures were confirmed to be in accordance with the Company Law, Shareholder Meeting Rules, and other relevant legal documents, ensuring the legitimacy of the resolutions passed [3]

Group 1 - The company is holding its first extraordinary general meeting of shareholders in 2025 to discuss the appointment of an external auditing firm for the year [2][4] - The meeting will utilize both on-site and online voting methods, with specific time slots for online voting [3][4] - The company emphasizes the importance of maintaining order during the meeting and the rights of shareholders to speak, inquire, and vote [2][3] Group 2 - The company proposes to appoint Zhongrui Cheng as the external auditing firm for 2025, following the decision that the previous auditor, Dahua, will not continue its services [4][7] - Zhongrui Cheng has a history dating back to 1997 and has developed into a large, comprehensive professional service organization, recognized as one of the top firms in China [5][6] - The total audit fee for 2025 is proposed to be 2.56 million yuan, which includes 2 million yuan for financial report auditing and 560,000 yuan for internal control auditing [7][8] Group 3 - The previous auditor, Dahua, provided an audit report for 2024 that included a disclaimer of opinion on the financial audit and a negative opinion on the internal control audit [7] - The company has communicated with both Dahua and Zhongrui Cheng regarding the change in auditing firms, and both parties are aware and have no objections to the transition [7][8] - The company’s board of directors is responsible for authorizing the management to sign agreements with the new auditing firm [8]